156 related articles for article (PubMed ID: 22866148)
1. Role of reactive oxygen species in the synergistic cytotoxicity of safingol-based combination regimens with conventional chemotherapeutics.
Ling LU; Tan KB; Chiu GN
Oncol Lett; 2011 Sep; 2(5):905-910. PubMed ID: 22866148
[TBL] [Abstract][Full Text] [Related]
2. The role of protein kinase C in the synergistic interaction of safingol and irinotecan in colon cancer cells.
Ling LU; Lin H; Tan KB; Chiu GN
Int J Oncol; 2009 Dec; 35(6):1463-71. PubMed ID: 19885570
[TBL] [Abstract][Full Text] [Related]
3. The role of reactive oxygen species and autophagy in safingol-induced cell death.
Ling LU; Tan KB; Lin H; Chiu GN
Cell Death Dis; 2011 Mar; 2(3):e129. PubMed ID: 21390063
[TBL] [Abstract][Full Text] [Related]
4. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
Batra S; Reynolds CP; Maurer BJ
Cancer Res; 2004 Aug; 64(15):5415-24. PubMed ID: 15289350
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells.
Schwartz GK; Haimovitz-Friedman A; Dhupar SK; Ehleiter D; Maslak P; Lai L; Loganzo F; Kelsen DP; Fuks Z; Albino AP
J Natl Cancer Inst; 1995 Sep; 87(18):1394-9. PubMed ID: 7658500
[TBL] [Abstract][Full Text] [Related]
6. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
Maurer BJ; Melton L; Billups C; Cabot MC; Reynolds CP
J Natl Cancer Inst; 2000 Dec; 92(23):1897-909. PubMed ID: 11106681
[TBL] [Abstract][Full Text] [Related]
7. Involvement of hydrogen peroxide in safingol-induced endonuclease G-mediated apoptosis of squamous cell carcinoma cells.
Hamada M; Wakabayashi K; Masui A; Iwai S; Imai T; Yura Y
Int J Mol Sci; 2014 Feb; 15(2):2660-71. PubMed ID: 24549171
[TBL] [Abstract][Full Text] [Related]
8. Liposomal codelivery of a synergistic combination of bioactive lipids in the treatment of acute myeloid leukemia.
Tan KB; Ling LU; Bunte RM; Chng WJ; Chiu GN
Nanomedicine (Lond); 2014 Aug; 9(11):1665-79. PubMed ID: 24294981
[TBL] [Abstract][Full Text] [Related]
9. In vivo efficacy of a novel liposomal formulation of safingol in the treatment of acute myeloid leukemia.
Tan KB; Ling LU; Bunte RM; Chng WJ; Chiu GN
J Control Release; 2012 Jun; 160(2):290-8. PubMed ID: 22100388
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in rat hepatic cytolethality of the protein kinase C inhibitor safingol: role of biotransformation.
Carfagna MA; Young KM; Susick RL
Toxicol Appl Pharmacol; 1996 Apr; 137(2):173-81. PubMed ID: 8661342
[TBL] [Abstract][Full Text] [Related]
11. Autophagy as a Survival Mechanism for Squamous Cell Carcinoma Cells in Endonuclease G-Mediated Apoptosis.
Masui A; Hamada M; Kameyama H; Wakabayashi K; Takasu A; Imai T; Iwai S; Yura Y
PLoS One; 2016; 11(9):e0162786. PubMed ID: 27658240
[TBL] [Abstract][Full Text] [Related]
12. Toxicity of the protein kinase C inhibitor safingol administered alone and in combination with chemotherapeutic agents.
Kedderis LB; Bozigian HP; Kleeman JM; Hall RL; Palmer TE; Harrison SD; Susick RL
Fundam Appl Toxicol; 1995 May; 25(2):201-17. PubMed ID: 7665004
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignancies.
Boulter AC; Maurer BJ; Pogue M; Kang MH; Cho H; Knight A; Reynolds CP; Quick D; Awasthi S; Gerber DE
Cancer Chemother Pharmacol; 2023 Aug; 92(2):97-105. PubMed ID: 37199745
[TBL] [Abstract][Full Text] [Related]
14. Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C.
Sachs CW; Safa AR; Harrison SD; Fine RL
J Biol Chem; 1995 Nov; 270(44):26639-48. PubMed ID: 7592889
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the Pentose-phosphate Pathway Selectively Sensitizes Leukemia Lymphocytes to Chemotherapeutics by ROS-independent Mechanism.
Zhelev Z; Ivanova D; Bakalova R; Aoki I; Higashi T
Anticancer Res; 2016 Nov; 36(11):6011-6020. PubMed ID: 27793928
[TBL] [Abstract][Full Text] [Related]
16. Safingol toxicology after oral administration to TRAMP mice: demonstration of safingol uptake and metabolism by N-acylation and N-methylation.
Morales PR; Dillehay DL; Moody SJ; Pallas DC; Pruett S; Allgood JC; Symolon H; Merrill AH
Drug Chem Toxicol; 2007; 30(3):197-216. PubMed ID: 17613006
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of the unnatural anticancer lipid safingol, L-threo-dihydrosphingosine, in cultured cells.
Dragusin M; Gurgui C; Schwarzmann G; Hoernschemeyer J; van Echten-Deckert G
J Lipid Res; 2003 Sep; 44(9):1772-9. PubMed ID: 12777464
[TBL] [Abstract][Full Text] [Related]
18. A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin.
Schwartz GK; Ward D; Saltz L; Casper ES; Spiess T; Mullen E; Woodworth J; Venuti R; Zervos P; Storniolo AM; Kelsen DP
Clin Cancer Res; 1997 Apr; 3(4):537-43. PubMed ID: 9815717
[TBL] [Abstract][Full Text] [Related]
19. Silver Nanotriangles and Chemotherapeutics Synergistically Induce Apoptosis in Glioma Cells via a ROS-Dependent Mitochondrial Pathway.
Yang H; Chen W; Ma J; Zhao J; Li D; Cao Y; Liu P
Int J Nanomedicine; 2020; 15():7791-7803. PubMed ID: 33116501
[TBL] [Abstract][Full Text] [Related]
20. Decitabine exerted synergistic effects with oxaliplatin in colorectal cancer cells with intrinsic resistance to decitabine.
Hosokawa M; Tanaka S; Ueda K; Iwakawa S; Ogawara KI
Biochem Biophys Res Commun; 2019 Jan; 509(1):249-254. PubMed ID: 30581001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
